PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 2, 2004 Subscribe to this News Feed    
 

Waters & Kraus accepting injury cases stemming from the Vioxx Ban

Vioxx is being voluntarily pulled off of shelves by drug maker Merck. Waters & Kraus Law Firm is currently handling Vioxx side effect lawsuits.

(PRWEB) October 2, 2004 -- On Thursday September 30, Merck voluntarily withdrew its arthritis drug Vioxx, after extensive research has shown the prescription drug can double the risk of heart attack. Vioxx is a nonsteroidal anti-inflammatory (NSAID) drug approved by the United States Food and Drug Administration in 1999 for the treatment of rheumatoid arthritis, osteoarthritis, menstrual cramps and acute pain in adults.

The Dallas, Texas based law firm of Waters & Kraus has been reviewing and accepting injury cases stemming from Vioxxs potential deadly side effects for over two years. Today the firm announced that it would be expanding its efforts and resources to assist those that have been injured by Vioxx. While Waters & Kraus is considered a large law firm with 32 skilled litigators, the firms founders insist that their trial attorneys carefully review and thoroughly evaluate each case prior to acceptance.

To learn more about the various side effects associated with Vioxx, and how the law firm of Waters & Kraus may be able to help you select the link below.

http://www.onlinelawyersource.com/news/drug-recall/vioxx-recall.html

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Dean Dowd
ONLINE LAWYER SOURCE
(214) 357-6244
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.